Rabbit Polyclonal cIAP1 antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications. Immunogen corresponding to Synthetic Peptide within Human BIRC2.
View Alternative Names
API1, MIHB, RNF48, BIRC2, Baculoviral IAP repeat-containing protein 2, Cellular inhibitor of apoptosis 1, IAP homolog B, Inhibitor of apoptosis protein 2, RING finger protein 48, RING-type E3 ubiquitin transferase BIRC2, TNFR2-TRAF-signaling complex protein 2, C-IAP1, hIAP-2, hIAP2
- WB
Unknown
Western blot - Anti-cIAP1 antibody (AB2399)
All lanes:
Western blot - Anti-cIAP1 antibody (ab2399)
All lanes:
Jurkat Cell lysate
Predicted band size: 70 kDa
Observed band size: 70 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CIAP1 plays an important role in regulating apoptosis by inhibiting the activity of certain caspases including caspase-3 and caspase-7. It is often part of larger protein complexes that include other members of the IAP family such as cIAP2. By binding directly to tumor necrosis factor receptor-associated factors (TRAFs) cIAP1 helps modulate signaling pathways that determine cell survival or death contributing to cellular homeostasis.
Pathways
CIAP1 is intricately involved in the NF-κB signaling pathway and the TNF receptor signaling pathway. Its interaction with TRAFs links it to these critical pathways helping to control inflammatory and immune responses. Other proteins related to cIAP1 through these pathways include RIP1 and TRAF2 both important for transmitting signals that affect cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 13:5493 PubMed36123338
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 47: PubMed35211761
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular immunology 18:1512-1527 PubMed32024978
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental hematology & oncology 9:1 PubMed31908904
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 18:364-375 PubMed30530769
2018
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 14:4586-4594 PubMed29104666
2017
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:425 PubMed28871172
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 7:39458-39472 PubMed27223062
2016
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 7:746-57 PubMed27076857
2016
Applications
WB
Species
Human
Oncotarget 6:8960-73 PubMed25840421
2015
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com